Exacerbations and their Outcomes International (EXACOS International)

Trial Identifier: D5980R00042
Sponsor: AstraZeneca
NCTID:: NCT04928417
Start Date: November 2021
Primary Completion Date: November 2022
Study Completion Date: November 2022
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Chile, Chile Santiago, Chile, Chile, 7580023
Mexico, Mexico Guadalajara, Mexico, Mexico, 44670
Mexico, Mexico Puebla, Mexico, Mexico, 72450
Russia, Russia Blagoveshensk, Russia, Russia, 675000
Russia, Russia Chelyabinsk, Russia, Russia, 454021
Russia, Russia Ekaterinburg, Russia, Russia, 620109
Russia, Russia Krasnoyarsk, Russia, Russia, 660037
Russia, Russia Moscow, Russia, Russia, 119991
Russia, Russia Omsk, Russia, Russia, 644005
Russia, Russia Petrozavodsk, Russia, Russia, 185019
Russia, Russia Saint-Petersburg, Russia, Russia, 199106
Russia, Russia Saint-Petersburg, Russia, Russia, 196247
Russia, Russia Voronezh, Russia, Russia, 394066
Taiwan, Taiwan Changhua City, Taiwan, Taiwan, 50006
Taiwan, Taiwan Kaohsiung City, Taiwan, Taiwan, 80756
Taiwan, Taiwan New Taipei City, Taiwan, Taiwan, 220
Taiwan, Taiwan Taichung City, Taiwan, Taiwan, 404332
Taiwan, Taiwan Taichung City, Taiwan, Taiwan, 40705
Taiwan, Taiwan Taipei City, Taiwan, Taiwan, 11217
Taiwan, Taiwan Taipei City, Taiwan, Taiwan, 100225
Taiwan, Taiwan Taoyuan City, Taiwan, Taiwan, 333